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j ourna l homepage: www.e lsev ie r .com/ locate /bbad is“From genome to function”This special issue “From genome to function” has been edited
by two researchers whose careers have grown along with the
rapid developments in this ﬁeld. In the early days, in the 1980s,
one of the goals of human geneticists was to identify DNA poly-
morphisms, map monogenic human diseases, and identify the
culprit genetic mutations and genes responsible for defects. This
proved to be an extremely laborious task, requiring multi-
million euro projects and large international teams to investigate
each disease. One of the dreams at that stage was to speed up the
discovery of genetic causes of disease by having a complete
human genetic map at hand, so that we could search for genetic
loci knowing that we had full genomic coverage. But it was still
a tremendous task to move from a genetic locus to gene discovery.
Hence, another dream was to have the complete annotated human
genome sequence available, so that we could hand pick genes for
further analysis without needing complex cloning strategies.
Technological advanceshavemade the challenges of the 1980s reality.
We are now witnessing a spectacular increase in the number of loci
known to determine monogenic as well as complex human diseases.
Soon, we will be able to sequence a human genome for as little as €800
(e.g. the $1000 genome).
This special issue addresses how we can push the boundaries
even further, now we have everything we dreamed of 20–
30 years ago. One key question is that how can we identify the
disease mechanisms now we know the associated genetic loci?
With expanding insights, we have started to appreciate the
complexity of many of the issues involved. We need to consider
not only the coding genes, but also the non-coding genes, and
we are now more aware of the role played by “the other
genome” in human well-being, i.e. the gut microbiome. This
issue has gathered papers on some of the modern technologies
and approaches used to identify the genetic variation underlying
certain disorders, as well as on the model systems being used to
study in depth the mechanisms that translate the genome into
function.http://dx.doi.org/10.1016/j.bbadis.2014.08.008
0925-4439/© 2014 Elsevier B.V. All rights reserved.Marten Hofker gained his PhD in Medicine at Leiden University (the
Netherlands) in 1987, for which he developed a set of X-chromosomal
markers that contributed to realizing tests for prenatal diagnosis and
1888 Prefacecarrier detection for Duchenne'smuscular dystrophy. He did postdoctoral
work in the Department of Genetics at the Hospital for Sick Children,
Toronto, on the genetic structure of the immunoglobulin heavy chain
gene. He later moved to the Department of Human Genetics, Leiden
University Medical Center, where he had a personal stipend from the
Netherlands Royal Academy of Arts and Sciences (KNAW) and an
established researcher grant from the Netherlands Heart Foundation
to work on the complex genetics of cardiovascular diseases.
In 2000 he became a Professor ofMolecular Genetics and head of the
respective department at Maastricht University Medical Center (the
Netherlands). Since 2007 he has held a similar position at University
Medical Center in Groningen. He is well known for his research on
metabolism and cardiovascular diseases using mouse models.Cisca Wijmenga gained her PhD in Medicine at Leiden University
(the Netherlands) in 1993, for which she mapped the genetic locus for
Facioscapulohumeral muscular dystrophy (FSHD) to chromosome 4q
and was able to identify a large deletion of the subtelomeric region as
its molecular cause. In 1994 she started postdoctoral work in a new
ﬁeld, working on the role of an inversion of chromosome 16 in acute
myeloid leukemia at the National Human Genome Research Institute
at NIH. During this period she became interested in the genetics of
complex diseases and in 1995 started her own group at Utrecht
University to study celiac disease. This work led her to the important
observation that several immune-mediated diseases share part of
their genetic basis. She is currently investigating the role of non-coding
RNAs in immune-mediated diseases and performing more functional
genomics studies, funded by a European Research Council advanced
grant. Her aim is to translate genetic ﬁndings into disease mechanisms.
In 2012 she was elected to the Netherlands Royal Academy of Arts and
Sciences (KNAW) and in 2013 to the Academia Europaea. She has been
head of the Department of Genetics at University Medical Center
Groningen since 2007.
